CAN-PACT: Advancing Psychedelic-Assisted Therapy in Oncology Supportive Care
The CAN-PACT initiative focuses on psychedelic-assisted therapy oncology supportive care for cancer patients experiencing demoralization syndrome. This multi-phase program emphasizes training, safety, and research infrastructure. It aims to establish…
GLP-1 Receptor Agonist Clinical Evidence: New Findings
GLP-1 receptor agonist clinical trial evidence provides critical insights into safety and emerging side effects. This evidence supports clinicians in monitoring patient outcomes effectively. Understanding these findings helps optimize GLP-1 therapy…
Schedule I Drug Classification: 3 Times Science Was Ignored
This meme isn’t exaggeration—it’s history repeating itself in policy. The Schedule I drug classification was meant to indicate substances with a high potential for abuse and no accepted medical use. But as science has evolved, that definition…